Cognition Therapeutics (CGTX) Prepaid Assets (2020 - 2026)
Cognition Therapeutics (CGTX) reported Prepaid Assets of $932000.0 for Q1 2026, down 43.86% year-over-year from $1.7 million in Q1 2025, and down 12.73% on a QoQ basis from $1.1 million in Q4 2025.
Cognition Therapeutics (CGTX) has 7 years of Prepaid Assets data on file, last reported at $932000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 43.86% year-over-year to $932000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $932000.0 (down 43.86% YoY) and the FY2025 annual result came in at $1.1 million, down 42.58% from the prior year.
- Prepaid Assets slipped to $932000.0 in Q1 2026 per CGTX's latest filing, from $1.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $3.0 million in Q4 2023 and bottomed at $932000.0 in Q1 2026.
- The 5-year median for Prepaid Assets is $1.8 million (2022), against an average of $1.8 million.
- The widest annual swing landed in 2022, when Prepaid Assets jumped 17840.0%; it then sank 43.86% in 2026.
- Tracing CGTX's Prepaid Assets over 5 years: stood at $2.4 million in 2022, then rose by 25.11% to $3.0 million in 2023, then tumbled by 38.39% to $1.9 million in 2024, then slumped by 42.58% to $1.1 million in 2025, then retreated by 12.73% to $932000.0 in 2026.
- Per Business Quant, the three latest CGTX Prepaid Assets figures stand at $932000.0 (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 932,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 1.16 Mn |
| Jun 30, 2025 | 1.21 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 1.45 Mn |
| Jun 30, 2024 | 1.92 Mn |
| Mar 31, 2024 | 2.44 Mn |
| Dec 31, 2023 | 3.02 Mn |
| Sep 30, 2023 | 1.43 Mn |
| Jun 30, 2023 | 1.97 Mn |
| Mar 31, 2023 | 2.38 Mn |
| Dec 31, 2022 | 2.41 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 1.68 Mn |
| Mar 31, 2022 | 2.14 Mn |
| Dec 31, 2021 | 2.01 Mn |
| Sep 30, 2021 | 10,000.00 |
| Dec 31, 2020 | 23,000.00 |